Mark Silverberg

Read how they describe their research on their University of Toronto profile.

• Effectiveness and Safety of Advanced Combination Treatment in Patients With Refractory Inflammatory Bowel Disease or Concomitant Immune-Mediated Disease or Extraintestinal Manifestations: A Multicenter Canadian Study

  American Journal of Gastroenterology · 2026

• Early Life Exposure to Parental Crohn’s Disease Is Associated With Offspring’s Gut Microbiome, Gut Permeability, and Increased Risk of Future Crohn’s Disease

  Gastroenterology · 2025

• Isolated Anastomotic Ulcers Are Associated with a Higher Long-Term Risk for Postoperative Recurrence and a Differential Mucosa-Associated Microbiome Composition in Patients with Crohn's Disease Following Ileocolic Resection.

  Inflammatory bowel diseases · 2025

• Immune response after COVID-19 vaccination during maintenance therapy in immune-mediated inflammatory diseases: an observational cohort study (IMPACT)

  CIHR · 2021 · Co-investigator

• Interplay of diet, bile acid-metabolizing bacteria and bile acid receptors as a gut microbiota-driven immunomodulatory pathway in inflammatory bowel disease

  CIHR · 2018 · Supervisor

  $55,000

• Innate immune regulation of intestinal homeostasis: insight into Crohn's disease pathogenesis.

  CIHR · 2014 · Co-investigator

  $2,404,680